Your browser doesn't support javascript.
loading
Epidemiological and clinical characteristics, and response to treatment in 113 patients with microscopic colitis. / Características epidemiológicas, clínicas y respuesta al tratamiento en 113 pacientes con colitis microscópica.
Rojo, Eukene; Casanova, María José; P Gisbert, Javier.
Afiliación
  • Rojo E; Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España. Electronic address: eukenerojo@hotmail.es.
  • Casanova MJ; Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España.
  • P Gisbert J; Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España.
Gastroenterol Hepatol ; 44(10): 671-679, 2021 Dec.
Article en En, Es | MEDLINE | ID: mdl-33248178
OBJECTIVE: To study the epidemiological and clinical characteristics, and response to treatment in patients with microscopic colitis. PATIENTS AND METHOD: Epidemiological, clinical, blood test and endoscopic data were retrospectively collected from 113 patients with microscopic colitis. Response to treatment was analyzed in 104 of them. Efficacy and relapse after treatment with budesonide were assessed using survival curves (Kaplan-Meier). RESULTS: 78% of the patients were women, with a mean age of 65 ± 16 years. In smokers, the mean age was 10 years younger. 48% of them had some concomitant autoimmune disease; 60% suffered a single outbreak of the disease. The clinical presentation was similar in both subtypes, although patients with collagenous colitis had a chronic course more frequently (48% vs. 29%, p = 0.047). The remission rate with budesonide was 93% (95% CI 82-98). The cumulative incidence of relapse, after a median follow-up of 21 months, was 39% (95% CI 26-54%): 19% at one year, 32% at two years, and 46% at three years of follow-up. There were no differences in clinical response to budesonide based on smoking habit or microscopic colitis subtype. CONCLUSIONS: Microscopic colitis is more frequent in elderly women. Smoking was associated with earlier onset of the disease, although it did not influence the clinical course or response to treatment. The majority (> 90%) of patients treated with budesonide achieved remission, although nearly half subsequently relapsed.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Colitis Microscópica Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En / Es Revista: Gastroenterol Hepatol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Colitis Microscópica Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En / Es Revista: Gastroenterol Hepatol Año: 2021 Tipo del documento: Article